Market Overview

UPDATE: Oppenheimer Upgrades UnitedHealth Group to Outperform; Valuation is Overly Pessimistic

Related UNH
Fast Money Picks For November 23
Obamacare Is Still Under Pressure; Here's Why
Insurance Stocks - Did We Miss The Boat? Or Is The Recent Run-Up An Overreaction To Expected Rate Increases? (Seeking Alpha)

Oppenheimer upgraded UnitedHealth Group (NYSE: UNH) from Perform to Outperform and raises the price target from $63.00 to $66.00.

Oppenheimer commented, "We believe that UNH's current discounted multiples appear attractive in light of the overly-pessimistic outlook regarding the impact of the ACA, and the recent pull-back related to MA rates. Furthermore, following the Q4:12 earnings conference call, we have increased confidence that FY2013 results will outperform expectations. With strong cash flow, a well-diversified portfolio and a strong track record of performance, we would be buyers of UNH."

UnitedHealth Group closed at $55.21 on Wednesday.

Latest Ratings for UNH

Sep 2015JP MorganInitiates Coverage onOverweight
Sep 2015Morgan StanleyAssumesOverweight
Jun 2015Sterne Agee CRTUpgradesNeutralBuy

View More Analyst Ratings for UNH
View the Latest Analyst Ratings

Posted-In: OppenheimerAnalyst Color Upgrades Analyst Ratings


Related Articles (UNH)

View Comments and Join the Discussion!

Get Benzinga's Newsletters